The integration of Big Data and Artificial Intelligence (AI) into healthcare systems has ushered in a new era of precision medicine and intelligent rehabilitation, particularly in the realms of oncology and physiotherapy. As cancer incidence and survivorship rates globally increase, the demand for effective, personalized and scalable treatment strategies has intensified. Big Data – characterized by its volume, variety, velocity, veracity and value – enables the aggregation and analysis of vast amounts of information from diverse sources such as electronic health records, wearable devices, medical imaging and genomics. Concurrently, AI technologies, including machine learning, deep learning and natural language processing, are being used to process this data, uncover hidden patterns, predict clinical outcomes and inform treatment decisions. In oncology, AI enhances early cancer detection, refines diagnostic accuracy, supports prognostic modeling and enables targeted therapies. In physiotherapy, these technologies personalize rehabilitation programs, facilitate remote monitoring and empower data-driven assessments of patient progress. The synergy between AI and Big Data bridges the gap between diagnosis and functional recovery, especially for cancer survivors who experience long-term impairments. This chapter explores the full spectrum of AI and Big Data applications in physiotherapy and cancer treatment – from foundational research to practical implementation. It discusses current technological advancements, translational pathways, real-world case studies and the integration of AI into clinical decision support systems. It also highlights challenges such as data standardization, algorithmic bias, privacy concerns and clinician adoption. By critically examining these elements, this study underscores the transformative potential of AI and Big Data to optimize patient outcomes, improve quality of life and streamline healthcare delivery in oncology and physiotherapy. The findings serve as a roadmap for future research and policy development aimed at fully harnessing these technologies across the continuum of cancer care. Cancer is one of the leading causes of morbidity and mortality worldwide, with the World Health Organization (WHO) reporting millions of new cases annually. Advances in early detection, targeted therapies and surgical interventions have improved survival rates for many cancers (Crosby et al. 2022). However, with increased survivorship comes the growing need for comprehensive rehabilitation strategies to manage long-term complications such as fatigue, neuropathy, pain, lymphedema and reduced functional capacity. Physiotherapy has emerged as an essential component of cancer care, addressing both the physical and psychological needs of patients during and after treatment. Concurrently, healthcare systems are undergoing a digital transformation driven by the advent of Big Data and Artificial Intelligence (AI) (Aminizadeh et al. 2024). These technologies are not merely enhancing existing clinical processes; they are fundamentally reshaping how diseases are diagnosed, treated and managed. Big Data refers to the collection and analysis of vast, complex datasets generated from various sources, including electronic health records (EHRs), medical imaging, wearable sensors, genetic sequencing and patient-reported outcomes. When appropriately harnessed, Big Data has the potential to reveal insights that would be impossible to uncover using traditional methods. AI encompasses a suite of technologies, such as machine learning (ML), deep learning (DL), natural language processing (NLP) and computer vision. These tools mimic human cognitive functions and are capable of learning from vast datasets, recognizing patterns, and making predictions or decisions with minimal human intervention. In oncology, AI algorithms have demonstrated remarkable capabilities in interpreting radiological and histopathological images, predicting disease progression and personalizing treatment protocols (Shmatko et al. 2022). In physiotherapy, AI is enabling more accurate movement analysis, personalized rehabilitation plans and remote patient monitoring through smart devices and sensors. The intersection of Big Data and AI is particularly promising for cancer treatment and rehabilitation. In oncology, precision medicine has become increasingly reliant on the integration of genomic, imaging and clinical data to tailor treatment strategies to individual patients. AI algorithms can rapidly analyze this data to identify actionable mutations, predict treatment response and flag high-risk cases for early intervention. In physiotherapy, AI models are being trained on thousands of data points from patient histories, biomechanics and therapy outcomes to create adaptive exercise regimens and monitor patient progress in real time (Mikolajewska et al. 2024). Moreover, cancer survivors often face chronic conditions that require long-term physiotherapy, which can be resource-intensive and difficult to standardize. AI-powered systems can address these challenges by enabling scalable, personalized and data-driven rehabilitation strategies. For example, motion capture technologies combined with AI can provide detailed assessments of patient mobility, flagging issues that may not be visible during traditional clinical evaluations. Similarly, virtual assistants and AI chatbots can support patients outside of clinical settings, offering real-time feedback, reminders and encouragement, thereby improving adherence to rehabilitation protocols (Aggarwal et al. 2023). While the potential benefits of integrating Big Data and AI into cancer care and physiotherapy are substantial, the path from research to practical application is not without challenges. First, the quality and consistency of healthcare data are often variable. Clinical data may be unstructured, incomplete or stored across siloed systems that are not easily interoperable. Standardizing data formats and ensuring the integrity of information is essential for reliable AI training and deployment. Additionally, there are significant ethical concerns surrounding the use of patient data, including issues of privacy, consent and algorithmic transparency. Ensuring that AI systems are explainable, fair and secure is critical to their acceptance and sustainability in clinical environments. Another barrier lies in the adoption and implementation of these technologies in clinical practice. Despite their potential, many AI and Big Data innovations remain confined to research settings or pilot programs (Pencheva et al. 2020). Clinicians may be hesitant to rely on algorithmic recommendations, particularly when the decision-making process is opaque. Furthermore, the integration of AI tools into existing healthcare workflows requires significant investment in infrastructure, training and interdisciplinary collaboration. Successful implementation depends not only on the robustness of the technology but also on the readiness of healthcare institutions and practitioners to adapt to new models of care. In this context, this chapter seeks to explore how Big Data and AI are transforming physiotherapy and cancer treatment, tracing the journey from foundational research to clinical practice. By examining current applications, technological advancements, case studies and implementation challenges, this study aims to provide a comprehensive understanding of this evolving landscape (Singh 2024). Special attention is given to the translational aspect – how cutting-edge research findings are being operationalized into real-world solutions that improve patient outcomes, enhance clinical efficiency and reduce healthcare disparities. This chapter begins by defining the fundamental concepts of Big Data and AI within a healthcare context, followed by an in-depth examination of their applications in oncology and physiotherapy. This includes the use of AI in cancer diagnostics, treatment planning and prognostic modeling, as well as in physiotherapy for movement analysis, personalized interventions and tele-rehabilitation (Vaniya et al. 2024). The integration of these technologies into combined oncology–physiotherapy care models is also explored, highlighting their role in survivorship programs and quality-of-life improvements. Subsequently, this chapter delves into the translational pathways that facilitate the shift from research to clinical implementation. This includes an overview of academic research trends, clinical trials incorporating AI and Big Data, and real-world examples of adoption in healthcare settings. Challenges such as data standardization, clinician–patient acceptance, regulatory compliance and ethical considerations are critically analyzed. Finally, this chapter presents future directions for research, policy and practice, including the development of multi-omics integration, real-world evidence frameworks and collaborative approaches that bridge the gap between data science and clinical care (Mohr et al. 2024). While the journey from research to practice is complex and multifaceted, the promise of these technologies to revolutionize patient care is undeniable. By understanding the mechanisms, opportunities and challenges of this integration, healthcare professionals, researchers and policymakers can work together to build a future in which intelligent, data-driven care is the standard for all patients – especially those navigating the complexities of cancer and rehabilitation. Big Data in healthcare refers to large volumes of complex health data derived from multiple sources, including EHRs, imaging, genomics, wearable devices and clinical trials. These data are characterized by the “5 Vs”: volume, velocity, variety, veracity and value. AI involves machine learning (ML), deep learning (DL), natural language processing (NLP) and computer vision technologies that simulate human intelligence to process data and support decision-making (Sarker 2022). AI systems can identify hidden patterns, predict outcomes and automate administrative and clinical tasks. The application of Big Data and AI in oncology represents a paradigm shift in how cancer is diagnosed, treated, and monitored. As cancer care becomes increasingly complex, the ability to process and interpret massive volumes of data – ranging from genetic profiles to imaging scans – is essential for delivering personalized and effective treatment. AI algorithms, trained on Big Data from diverse populations and cancer types, are capable of uncovering patterns that elude conventional analysis. This enables oncologists to make more informed decisions, reduce uncertainty and optimize patient outcomes across the cancer care continuum. Precision oncology is one of the most impactful areas where Big Data and AI are being leveraged (Dlamini et al. 2020). The approach aims to tailor cancer treatment based on the individual genetic and molecular profile of each patient. AI algorithms analyze data from next-generation sequencing (NGS), whole-genome and exome sequencing, and transcriptomics to identify actionable mutations and molecular targets. For instance, machine learning models are used to predict patient responsiveness to specific therapies such as tyrosine kinase inhibitors, checkpoint inhibitors, or CAR-T (Chimeric Antigen Receptor) cell therapy. These predictions are based on integrated datasets that include genomic alterations, tumor microenvironment characteristics and historical treatment responses. Pharmacogenomic databases such as The Cancer Genome Atlas (TCGA) and cBioPortal, coupled with AI-driven analytical platforms, facilitate the identification of biomarkers and potential therapeutic targets. NLP also plays a crucial role in mining unstructured clinical notes and scientific literature to match patients with the most appropriate clinical trials or experimental therapies (Chen et al. 2020). As a result, precision oncology not only enhances treatment efficacy but also minimizes adverse effects by avoiding ineffective interventions. Early detection is critical for improving cancer survival rates, and AI has emerged as a powerful ally in diagnostic radiology and pathology. Deep learning models trained on vast datasets of radiological images – such as mammograms, CT scans, PET scans and MRIs – can detect tumors with sensitivity and specificity often comparable to (or exceeding that of) experienced clinicians. For example, convolutional neural networks (CNNs) are widely used to analyze breast cancer mammograms, detecting microcalcifications or lesions that may be missed in routine screenings. AI is also transforming the field of digital pathology. Whole-slide imaging (WSI) combined with AI algorithms can automate the classification, grading and staging of various cancers. These tools reduce diagnostic variability and speed up workflows, particularly in regions with limited access to trained pathologists. Additionally, AI-based decision support systems can flag suspicious findings for further review, facilitating earlier intervention.
12
Big Data and AI in Physiotherapy and Cancer Treatment: From Research to Practice
12.1. Introduction
12.2. Big Data and AI: definitions and scope
12.2.1. What is Big Data?
12.2.2. What is AI in healthcare?
12.3. Big Data and AI in oncology
12.3.1. Precision oncology
12.3.2. Early detection and diagnosis
Related posts:
AI-driven Imaging in Oncology and Physiotherapy: A Game-changer in Diagnostics
AI-enhanced Virtual Rehabilitation: The Future of Cancer Recovery
Integrating AI with Physiotherapy to Improve Quality of Life for Cancer Patients
Personalized AI-based Exercise Therapy for Oncology and Physiotherapy Patients
AI-driven Innovations in Biomaterial-based Physiotherapy and Oncology: Personalizing Patient Care Through Intelligent Monitoring and Predictive Rehabilitation
Enhancing Health Data Security and Intelligence with Blockchain and Artificial Intelligence
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
